Pulse Biosciences, Inc.
PLSE· Nasdaq
Filed Mar 16, 2018 · 10-K · 75 days after period end · 0001625101-18-000012
| Metric | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|
| Net Income | -$8.70M | -$2.81M | -$1.02M |
| EPS Diluted | -$0.53 | -$0.21 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 16, 2018 · 75 d after period end